Stocks
Denali Therapeutics (DNLI) P/S US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 62.4 | 27.2 | 111.4 | 32.2 | 8.92 | 10.9 | ||
| Changes by years, y/y, % | +321% | -56% | +310% | -71% | -72% | -9.7% | |||
Denali Therapeutics. P/S
Denali Therapeutics. P/S, changes, %
Denali Therapeutics (DNLI) P/S US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/S | ? | 8.33 | 116.4 | 0.00 | 0.00 | 0.00 | 10.9 | |
| Changes by years, y/y, % | -76% | +242% | -100% | -100% | -100% | |||
| Changes by quarters, q/q, % | -29% | +1 297% | -100% | |||||
